Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, November 11 at 2:00 PM ET

Register Free →

This Award Notice opportunity from Department Of Veterans Affairs was posted on December 18, 2025. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

6505--Cefuroxime Tablets (VA-26-00005794)

Awarded
36E79725R0059Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

AI Contract Overview

Show more

The Department of Veterans Affairs awarded contract 36E79726D0008 to A-S Medication Solutions LLC, located in Libertyville, Illinois, for the procurement of Cefuroxime Tablets. The award, issued on December 18, 2025, under solicitation 36E79725R0059, has a total value of $940,366.32. The contract falls under NAICS code 325412 for Pharmaceutical Preparation Manufacturing and Product Service Code 6505. The scope of work involves the supply of Cefuroxime Tablets across four contract line items. While specific delivery schedules and packaging requirements are not detailed, the contract is managed by the Department of Veterans Affairs office in Hines, Illinois, with Adrienne Albachiara serving as the primary Contract Specialist. The procurement implies adherence to federal pharmaceutical standards, including FDA current Good Manufacturing Practices and United States Pharmacopeia standards, given the nature of the medical supplies.

General Info

Contract Value

$0

NAICS

325412 - Pharmaceutical Preparation Manufacturing

Place of Performance

IL, USA

Set-Aside

NONE

Award Issued Date

Documents

1
DOCX, Low priorityaward
Low

AI Contract Breakdown

Uniform Contract Format

Sign up to view the full breakdown with detailed analysis of each section.

Timeline

PhaseAwarded
Posted

Award Notice

Awarded

Contract was awarded

Find active opportunities like this

Get full access to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyDepartment Of Veterans Affairs → Nac Pharmaceuticals (36E797)
Contacts1 person available
OfficeHINES, IL, 60141, USA
Office AddressHINES, IL, 60141, USA
Contacts
Adrienne AlbachiaraContract Specialist

Full Description

Show more
https://api.sam.gov/prod/opportunities/v1/noticedesc?noticeid=4f78d67201a44af7af9c2f484841f533

More opportunities from Department Of Veterans Affairs → Nac Pharmaceuticals (36E797)

Same awarding agency

NAICS: 325412
Federal
6505--Latanoprost Ophthalmic Solution (VA-27-00006027)
Solicitation # 36E79727R0039
The Department of Veterans Affairs is soliciting proposals for the procurement of Latanoprost 0.005% Ophthalmic Solution to ensure an uninterrupted supply for the VA, Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Center. This unrestricted commercial item procurement is structured into two groups, with one award made in the aggregate for either Group I (single bottles) or Group II (single and bulk cartons). The resulting contract will consist of a one-year base period followed by four pre-priced one-year option periods. Distribution will be managed through the VA and DoD Pharmaceutical Prime Vendor Programs, requiring the contractor to deliver supplies to designated distribution centers based on business-to-business agreements. Award will be granted based on the lowest evaluated price among proposals that meet all non-cost acceptability standards. Offerors must provide a unique 11-digit NDC number and adhere to the American Academy of Ophthalmology’s uniform color-coding system for caps and labels. Strict compliance with FDA current Good Manufacturing Practice standards is required, and offerors must certify they possess the necessary NDA, ANDA, or BLA approvals. Additionally, products must meet rigorous barcoding and serialization requirements under the Drug Supply Chain Security Act, including the use of GS-1 data matrix codes. Proposals must be submitted by November 17, 2026, and must include a 0.5% cost recovery fee embedded in the pricing.
Pharmaceutical Preparation Manufacturing

POSTED

10 days ago

DEADLINE

in 9 days
View Details

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS